Inogen registered for an initial public offering worth up to $86.3 million IPO, saying it plans to will trade on the NASDAQ exchange under the INGN symbol.
The Goleta, Calif.-based medical device company makes oxygen concentrators used to deliver supplemental oxygen therapy to patients suffering from chronic respiratory conditions.
Inogen has yet to determine the number of shares it will offer, or their price range, according to a regulatory filing.
Inogen said it pared its losses for the 9 months ended Sept. 30. by more than 48%, to -$1.9 million, on sales growth of 60.3% to $55.7 million.*